Physician profile
Eric Steven Bour
NPI 1548245913
$84,405.00
in general payments reported to CMS, 2019-2025
14 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $394 · 2021: $12K · 2022: $10K · 2023: $36K · 2024: $14K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $5,402 · Education: $5,000 · Food and Beverage: $3,694 · Honoraria: $1,000 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,790.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,700.00 |
| Travel and Lodging | $5,402.34 |
| Education | $5,000.00 |
| Food and Beverage | $3,693.55 |
| Honoraria | $1,000.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $50,543.75 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $31,597.56 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Pacira Pharmaceuticals Incorporated | $1,000.00 | 2024 | Iovera, Exparel |
| Lucid Diagnostics INC. | $420.86 | 2021-2023 | |
| Heron Therapeutics, INC. | $208.18 | 2021 | |
| Olympus America INC. | $165.73 | 2019-2021 | |
| Asensus Surgical, INC. | $151.15 | 2019 | |
| Ethicon US, LLC | $127.48 | 2021-2025 | Echelon Flex, Echelon Endopath, Stratafix |
| Endogastric Solutions, INC | $64.03 | 2021-2024 | Esophyx |
| Medtronic, INC. | $34.81 | 2024-2025 | Dextile, Signia |
| Davol INC. | $34.09 | 2021-2023 | Phasix Mesh |
| Boston Scientific Corporation | $22.54 | 2025 | Spyglass Discover |
| Myriad Genetic Laboratories, INC. | $18.70 | 2025 | Myrisk |
| Conmed Corporation | $16.12 | 2025 | Conmed Specimen Retrieval |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.